IRMD
IRadimed Corporation
Platform & Compounding FCF
A-
86.0 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
15.7%
-
Operating Margin Trend
+1.61 pp/yr
-
5yr Avg ROE
17.1%
-
5yr Share-Count CAGR
0.5%
-
5yr Revenue CAGR
19.0%
-
5yr EPS CAGR
24.0%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
18.7%
-
5yr FCF/NI Conversion
0.75x
-
Net Debt / EBITDA
-1.79x
-
Interest Coverage (EBIT/Int)
30.00x
-
Altman Z-Score
47.69
Stability
Weight: 5%
C-
49
-
EPS Volatility (σ/μ)
0.66
-
Piotroski F-Score
5
-
Negative-Revenue Years (5)
0/5
2 of 2 gurus held; 2 added.
- Holders
- 2
+1
- Avg Δ position
-
+30.4%
- New buys
- 0
- Full exits
- 0